Program

131
30
10
7
7
3
2
2
1

Journal Year Published

5
9
9
7
7
12
13
17
17
12
33
21
8
3
3

Author

177
185
145
136
127
123
118
117
108
97
88
81
77
58
54
50
46
46
42
37

Category

78
66
29
29
23
12
8
8
6
4
1

Keyword

99
49
36
35
32
24
23
20
17
16
14
14
13
12
12
11
11
10
10
10

Journal

12
10
9
8
8
7
7
5
5
5
4
4
4
3
3
3
3
3
2
2

NCATS Publications

The Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug Discovery.


Coussens NP, et al.


Clin Transl Sci , 2018.

Article Pubmed

Sample image from publication page

Recommendations toward a human pathway-based approach to disease research.


Marshall LJ, Austin C, Casey W, Fitzpatrick SC, Willett C


Drug Discov. Today , 2018.

Article Pubmed

Sample image from publication page

Translating translation.


Austin C


Nat Rev Drug Discov , 2018.

Article Pubmed

Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development.


Wagner JA, Dahlem AM, Hudson LD, Terry SF, Altman RB, Gilliland CT, DeFeo C, Austin C


Clin Transl Sci , 2017.

Article Pubmed

Sample image from publication page

A dynamic map for learning, communicating, navigating and improving therapeutic development.


Wagner J, Dahlem AM, Hudson LD, Terry SF, Altman RB, Gilliland CT, DeFeo C, Austin C


Nat Rev Drug Discov , 2017.

Article Pubmed

Sample image from publication page

The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact.


Lochmüller H, Torrent I Farnell J, Le Cam Y, Jonker AH, Lau LP, Baynam G, Kaufmann P, Dawkins HJ, Lasko P, Austin C, Boycott KM, IRDiRC Consortium Assembly


Eur. J. Hum. Genet. , 2017.

Article Pubmed

Sample image from publication page

Voluntary Site Accreditation - Improving the Execution of Multicenter Clinical Trials.


Johnston SC, Austin C, Lewis-Hall F


N. Engl. J. Med. , (377), 1414-1415, 2017.

Article Pubmed

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.


Ory DS, Ottinger E, Farhat NY, King KA, Jiang X, Weissfeld L, Berry-Kravis E, Davidson C, Bianconi S, Keener LA, Rao R, Soldatos A, Sidhu R, Walters KA, Xu X, Thurm A, Solomon B, Pavan WJ, Machielse BN, Kao M, Silber SA, McKew JC, Brewer CC, Vite CH, Walkley SU, Austin C, Porter FD


Lancet , 2017.

Article Pubmed

Sample image from publication page

Future of Rare Diseases Research 2017-2027: an IRDiRC Perspective.


Austin C, Cutillo C, Lau LP, Jonker AH, Rath A, Julkowska D, Thomson D, Terry S, de Montleau B, Ardigò D, Hivert V, Boycott KM, Baynam G, Kaufmann P, Taruscio D, Lochmüller H, Suematsu M, Incerti C, Draghia-Akli R, Norstedt I, Wang L, Dawkins HJ, International Rare Diseases Research Consortium (IRDiRC)


Clin Transl Sci , 2017.

Article Pubmed